変形性関節症治療の市場レポート：解剖学タイプ、薬剤タイプ、投与経路、流通チャネル、地域別、2025年～2033年

世界の変形性関節症治療市場規模は2024年に85億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに153億米ドルに達し、2025年から2033年にかけて6.82%の成長率（CAGR）を示すと予測しています。

変形性関節症（OA）は、膝、臀部、手、足、脊椎、肩、首の関節における軟骨の進行性変性を特徴とする異種の疾患です。OAでは一般に、こわばり、腫れ、圧痛、持続的な痛み、柔軟性の低下、耳障りな感覚、骨棘、睡眠障害などが生じる。身体診察、X線検査、関節鏡検査、関節液分析、血液検査、MRI検査などで診断されます。この病気の徴候や症状を緩和するために、さまざまな薬物療法や外科手術がさまざまな結果に応じて処方されます。現在、痛みを和らげ関節機能を改善するために、代替薬、理学療法、補助器具が市場に出回っています。

世界の変形性関節症治療市場動向と促進要因：

座りがちなライフスタイル、不健康な食事パターン、肥満や血糖値の上昇により、OA発症のリスクが高まっています。これは、このような病気にかかりやすい老年人口の増加と相まって、変形性関節症治療市場の成長を促す重要な要因の一つとなっています。これとは別に、MRI検査への容易なアクセスがもう1つの主要な成長促進要因として作用しています。さらに、X線写真の特徴に基づく画像バイオマーカーの開発と鎮痛薬の導入が市場拡大に寄与しています。さらに、新しい診断薬やバイオマーカーを上市するための研究開発活動への投資が増加していることや、ヘルスケアインフラの改善への支出が増加していることも市場を牽引しています。例えば、軟骨破壊を治療するための炎症性サイトカインに注目した疾患修飾薬の開発が進められています。

本レポートで扱う主な質問

• 2024年の世界の変形性関節症治療市場規模は？
• 2025年から2033年にかけての変形性関節症治療世界市場の予想成長率は？
• 変形性関節症治療の世界市場を牽引する主要因は何か？
• 変形性関節症治療の世界市場におけるCOVID-19の影響は？
• 変形性関節症治療の世界市場における解剖学タイプ別の区分は？
• 薬剤タイプに基づく変形性関節症治療世界市場の内訳は？
• 投与経路に基づく変形性関節症治療世界市場の内訳は？
• 変形性関節症治療の世界市場における流通チャネル別の区分は？
• 変形性関節症治療の世界市場における主要地域は？
• 変形性関節症治療の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の変形性関節症治療市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：解剖学タイプ別

• 膝
• ヒップ
• 手
• 脊椎
• その他

第7章 市場内訳：薬剤タイプ別

• 非ステロイド性抗炎症薬
• 鎮痛剤
• コルチコステロイド
• その他

第8章 市場内訳：投与経路別

• 非経口
• 外用
• 経口

第9章 市場内訳：流通チャネル別

• 病院
• 専門クリニック
• 医療機関
• その他

第10章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • Anika Therapeutics Inc.
  • Bayer Aktiengesellschaft
  • Eli Lilly and Company
  • Flexion Therapeutics Inc.
  • GlaxoSmithKline Plc
  • Horizon Therapeutics Plc
  • Johnson & Johnson Inc.
  • Pfizer Inc.
  • Sanofi S.A

List of Figures

• Figure 1: Global: Osteoarthritis Therapeutics Market: Major Drivers and Challenges
• Figure 2: Global: Osteoarthritis Therapeutics Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Osteoarthritis Therapeutics Market: Breakup by Anatomy Type (in %), 2024
• Figure 4: Global: Osteoarthritis Therapeutics Market: Breakup by Drug Type (in %), 2024
• Figure 5: Global: Osteoarthritis Therapeutics Market: Breakup by Route of Administration (in %), 2024
• Figure 6: Global: Osteoarthritis Therapeutics Market: Breakup by Distribution Channel (in %), 2024
• Figure 7: Global: Osteoarthritis Therapeutics Market: Breakup by Region (in %), 2024
• Figure 8: Global: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 9: Global: Osteoarthritis Therapeutics (Knee) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Osteoarthritis Therapeutics (Knee) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Osteoarthritis Therapeutics (Hip) Market: Sales Value (in Million USD), 2019 & 2024

Figure 12 Global: Osteoarthritis Therapeutics (Hip) Market Forecast: Sales Value (in Million USD), 2025-2033

• Figure 13: Global: Osteoarthritis Therapeutics (Hand) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Osteoarthritis Therapeutics (Hand) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Osteoarthritis Therapeutics (Spine) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Osteoarthritis Therapeutics (Spine) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Osteoarthritis Therapeutics (Analgesics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Osteoarthritis Therapeutics (Analgesics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Osteoarthritis Therapeutics (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Osteoarthritis Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Osteoarthritis Therapeutics (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Global: Osteoarthritis Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: Global: Osteoarthritis Therapeutics (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: Global: Osteoarthritis Therapeutics (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Global: Osteoarthritis Therapeutics (Topical) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Global: Osteoarthritis Therapeutics (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: Global: Osteoarthritis Therapeutics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Global: Osteoarthritis Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: Global: Osteoarthritis Therapeutics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: Global: Osteoarthritis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Global: Osteoarthritis Therapeutics (Medical Institutions) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Global: Osteoarthritis Therapeutics (Medical Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: North America: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: North America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: United States: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: United States: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: Canada: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: Canada: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: Asia Pacific: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: Asia Pacific: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: China: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: China: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Japan: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Japan: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: India: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: India: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: South Korea: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: South Korea: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Australia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Australia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Indonesia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Indonesia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: Europe: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: Europe: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: Germany: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: Germany: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: France: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: France: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 69: United Kingdom: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 70: United Kingdom: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 71: Italy: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 72: Italy: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 73: Spain: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 74: Spain: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 75: Russia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 76: Russia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 77: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 78: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 79: Latin America: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 80: Latin America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 81: Brazil: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 82: Brazil: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 83: Mexico: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 84: Mexico: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 85: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 86: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 87: Middle East and Africa: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
• Figure 88: Middle East and Africa: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 89: Global: Osteoarthritis Therapeutics Industry: SWOT Analysis
• Figure 90: Global: Osteoarthritis Therapeutics Industry: Value Chain Analysis
• Figure 91: Global: Osteoarthritis Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Osteoarthritis Therapeutics Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Anatomy Type (in Million USD), 2025-2033
• Table 3: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
• Table 4: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
• Table 5: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
• Table 6: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 7: Global: Osteoarthritis Therapeutics Market: Competitive Structure
• Table 8: Global: Osteoarthritis Therapeutics Market: Key Players

The global osteoarthritis therapeutics market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.3 Billion by 2033, exhibiting a growth rate (CAGR) of 6.82% during 2025-2033.

Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan. Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.

Global Osteoarthritis Therapeutics Market Trends and Drivers:

Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the osteoarthritis therapeutics market growth. Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth. Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown.

Key Market Segmentation:

Breakup by Anatomy Type:

• Knee
• Hip
• Hand
• Spine
• Others

Breakup by Drug Type:

• Nonsteroidal Anti-Inflammatory Drugs
• Analgesics
• Corticosteroids
• Others

Breakup by Route of Administration:

• Parenteral
• Topical
• Oral

Breakup by Distribution Channel:

• Hospitals
• Specialty Clinics
• Medical Institutions
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report

• 1.What was the size of the global osteoarthritis therapeutics market in 2024?
• 2.What is the expected growth rate of the global osteoarthritis therapeutics market during 2025-2033?
• 3.What are the key factors driving the global osteoarthritis therapeutics market?
• 4.What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
• 5.What is the breakup of the global osteoarthritis therapeutics market based on the anatomy type?
• 6.What is the breakup of the global osteoarthritis therapeutics market based on the drug type?
• 7.What is the breakup of the global osteoarthritis therapeutics market based on the route of administration?
• 8.What is the breakup of the global osteoarthritis therapeutics market based on the distribution channel?
• 9.What are the key regions in the global osteoarthritis therapeutics market?
• 10.Who are the key players/companies in the global osteoarthritis therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Osteoarthritis Therapeutics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Anatomy Type

• 6.1 Knee
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Hip
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Hand
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Spine
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Drug Type

• 7.1 Nonsteroidal Anti-Inflammatory Drugs
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Analgesics
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Corticosteroids
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

• 8.1 Parenteral
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Topical
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Oral
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Specialty Clinics
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Medical Institutions
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Anika Therapeutics Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Bayer Aktiengesellschaft
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Eli Lilly and Company
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Flexion Therapeutics Inc.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
  • 15.3.6 GlaxoSmithKline Plc
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Horizon Therapeutics Plc
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Johnson & Johnson Inc.
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Pfizer Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Sanofi S.A
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis